Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
Sponsor: St. Luke's Hospital and Health Network, Pennsylvania
Terminated
unable to enroll sufficient number of participants
A NA clinical study on Prevention of Hangover Using N-Acety Cysteine, this trial is terminated or withdrawn. The trial is conducted by St. Luke's Hospital and Health Network, Pennsylvania and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2018 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Luke's Hospital and Health Network, Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .